Takeda Pharmaceutical Co., Ltd./ JP3463000004 /
2024-11-07 3:30:00 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
26.7600USD | - | 119,689 Turnover: 7,599.8400 |
-Bid Size: - | -Ask Size: - | 43.41 bill.USD | - | - |
Assets
2014 - in mill. JPY |
2015 - in mill. JPY |
2016 - in mill. JPY |
2017 - in mill. JPY |
2018 - in mill. JPY |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 542,253 | 526,162 | 551,916 | 527,344 | 536,801 | ||||||
Intangible Assets | 1.14 mill. | 939,381 | 743,128 | 1.07 mill. | 1.01 mill. | ||||||
Long-Term Investments | 0.0000 | 241,323 | 149,548 | 126,411 | 107,949 | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 254,329 | 262,354 | 254,010 | 226,048 | 212,944 | ||||||
Accounts Receivable | 430,620 | 444,681 | 415,379 | 423,405 | 420,247 | ||||||
Cash and Cash Equivalents | 666,048 | 652,148 | 451,426 | 319,455 | 294,522 | ||||||
Current Assets | 1.59 mill. | 1.52 mill. | 1.37 mill. | 1.26 mill. | 1.08 mill. | ||||||
Total Assets | 4.57 mill. | 4.3 mill. | 3.82 mill. | 4.35 mill. | 4.11 mill. |
Liabilities
2014 - in mill. JPY |
2015 - in mill. JPY |
2016 - in mill. JPY |
2017 - in mill. JPY |
2018 - in mill. JPY |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 184,900 | 170,782 | 191,089 | 240,623 | 240,259 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 204,221 | 142,070 | 265,632 | 545,028 | 18 | ||||||
Provisions | 347,326 | 244,278 | 201,023 | 270,213 | 186,461 | ||||||
Liabilities | 2.03 mill. | 2.09 mill. | 1.81 mill. | 2.41 mill. | 2.09 mill. | ||||||
Share Capital | 63,562 | 64,044 | 64,766 | 65,203 | 77,914 | ||||||
Total Equity | 2.54 mill. | 2.21 mill. | 2.01 mill. | 1.95 mill. | 2.02 mill. | ||||||
Minority Interests | 69,896 | 69,129 | 62,511 | 54,704 | 19,985 | ||||||
Total liabilities equity | 4.57 mill. | 4.3 mill. | 3.82 mill. | 4.35 mill. | 4.11 mill. |
Income Statement
2014 - in mill. JPY |
2015 - in mill. JPY |
2016 - in mill. JPY |
2017 - in mill. JPY |
2018 - in mill. JPY |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.69 mill. | 1.78 mill. | 1.81 mill. | 1.73 mill. | 1.77 mill. | ||||||
Depreciation (total) | 143,202 | 176,402 | 125,140 | 156,717 | 122,131 | ||||||
Operating Result | 139,274 | -129,254 | 130,828 | 155,867 | 241,789 | ||||||
Interest Income | 18,577 | -17,521 | -10,286 | -10,976 | 7,615 | ||||||
Income Before Taxes | 158,851 | -145,437 | 120,539 | 143,346 | 217,205 | ||||||
Income Taxes | 49,292 | -2,403 | 37,059 | 27,833 | 30,497 | ||||||
Minority Interests Profit | -2,900 | -2,741 | -3,313 | -573 | 178 | ||||||
Net Income | 106,658 | -145,775 | 80,166 | 114,940 | 186,886 |
Per Share
Cash Flow
2014 - in mill. JPY |
2015 - in mill. JPY |
2016 - in mill. JPY |
2017 - in mill. JPY |
2018 - in mill. JPY |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 148,335 | 182,517 | 25,491 | 261,363 | 377,854 | ||||||
Cash Flow from Investing Activities | -158,611 | 91,347 | -71,208 | -655,691 | -93,342 | ||||||
Cash Flow from Financing | 101,441 | -300,998 | -124,839 | 289,896 | -326,226 | ||||||
Decrease / Increase in Cash | 29,303 | -27,134 | -170,557 | -104,432 | -41,714 | ||||||
Employees | 31,225 | 31,328 | 31,168 | - | 27,230 |